Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-Current Debt: 2019-2025

Historic Non-Current Debt for Puma Biotechnology (PBYI) over the last 4 years, with Jun 2025 value amounting to $10.9 million.

  • Puma Biotechnology's Non-Current Debt fell 75.15% to $10.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.9 million, marking a year-over-year decrease of 75.15%. This contributed to the annual value of $21.7 million for FY2024, which is 66.92% down from last year.
  • As of Q2 2025, Puma Biotechnology's Non-Current Debt stood at $10.9 million, which was up 2.09% from $10.6 million recorded in Q1 2025.
  • Puma Biotechnology's 5-year Non-Current Debt high stood at $98.6 million for Q1 2023, and its period low was $10.6 million during Q1 2025.
  • Moreover, its 3-year median value for Non-Current Debt was $49.2 million (2024), whereas its average is $50.3 million.
  • Per our database at Business Quant, Puma Biotechnology's Non-Current Debt surged by 42.17% in 2022 and then plummeted by 80.53% in 2025.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Non-Current Debt stood at $97.1 million in 2021, then climbed by 1.25% to $98.3 million in 2022, then crashed by 33.21% to $65.7 million in 2023, then slumped by 66.92% to $21.7 million in 2024, then crashed by 75.15% to $10.9 million in 2025.
  • Its Non-Current Debt was $10.9 million in Q2 2025, compared to $10.6 million in Q1 2025 and $21.7 million in Q4 2024.